Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 145-156 of 4,306
Drug study icon
RecruitingNCT07122895

Sex Differences in NMDA-enhancing Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taichung
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 20 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Other study type icon
RecruitingNCT07419321

Social Isolation and Aging in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hartford
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 40 Years to 70 Years
Countries
United States, United Kingdom, Netherlands, ...
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
Drug study icon
RecruitingNCT06502964

ALTO-101 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 21 Years to 55 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Schizophrenia
Drug study icon
RecruitingNCT07467993

Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States and in Bulgaria.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
Drug study icon
RecruitingNCT07565428

Roluperidone for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bellflower
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
Drug study icon
RecruitingNCT07363577

LB-102 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
RecruitingNCT05958875

Effect of a Six Week Intensified Pharmacological Treatment for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United Kingdom, in Austria, in Germany, ...

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United Kingdom, Austria, Germany, ...
Sponsor
Dr. Inge Winter
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.